(Q77406873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Infliximab treatment of severe ankylosing spondylitis: one-year followup (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

main subject

ankylosing spondylitis

1 reference

J Brandt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

H Haibel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Sieper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Reddig

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Braun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

2936-2937

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2936%3A%3AAID-ART483%3E3.0.CO%3B2-M

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2936%3A%3AAID-ART483%3E3.0.CO%3B2-M

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2936%3A%3AAID-ART483%3E3.0.CO%3B2-M

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2936%3A%3AAID-ART483%3E3.0.CO%3B2-M

10.1002/1529-0131(200112)44:12<2936::AID-ART483>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762956%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference